Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torrelles

Showing results (211-220 of 245) with videos related to

Pageof 25
Sort By:
AIDS Research and Therapy|October 21, 2022
Correction to: Accuracy of the tuberculosis point-of-care Alere determine lipoarabinomannan antigen diagnostic test using α-mannosidase treated and untreated urine in a cohort of people living with HIV in GuatemalaJuan Ignacio García, Johanna Meléndez, Rosa Álvarez, et al.
Lab Animal|June 4, 2026
The study of immunological markers in tuberculosis across animal models and its translation to human researchSergio Díaz-Fernández, Matilde Aleluia, Margarida Saraiva, et al.
Pathogens (Basel, Switzerland)|December 23, 2022
Differential Role of Type 2 Diabetes as a Risk Factor for Tuberculosis in the Elderly versus Younger AdultsBlanca I Restrepo, Julia M Scordo, Génesis P Aguillón-Durán, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 15, 2021
Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2Kenneth S Plante, Varun Dwivedi, Jessica A Plante, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
Modeling SARS-CoV-2 and Influenza Infections and Antiviral Treatments in Human Lung Epithelial Tissue EquivalentsHoda Zarkoob, Anna Allué-Guardia, Yu-Chi Chen, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
SARS-CoV-2 B.1.1.7 and B.1.351 variants of concern induce lethal disease in K18-hACE2 transgenic mice despite convalescent plasma therapyAlexander M Horspool, Chengjin Ye, Ting Y Wong, et al.
Journal of Virology|September 8, 2021
A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern <i>In Vitro</i> and <i>In Vivo</i>Kevin Chiem, Desarey Morales Vasquez, Jesus A Silvas, et al.
Leukemia Research|October 14, 2023
Venetoclax with hypomethylating agents might lead to eradication of measurable residual disease (MRD) persisting after intensive chemotherapy in acute myeloid leukemia (AML) patients with mutated NPM1 and rearranged CBFCarlos Jiménez-Vicente, Alexandra Martínez-Roca, Helena Pomares, et al.
Research Square|April 1, 2024
Interaction between type 2 diabetes and past COVID-19 on active tuberculosisLiz E Calles-Cabanillas, Genesis P Aguillón-Durán, Doris Ayala, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 22, 2023
Extracellular Delivery of Functional Mitochondria Rescues the Dysfunction of CD4<sup>+</sup> T Cells in AgingColwyn A Headley, Shalini Gautam, Angelica Olmo-Fontanez, et al.
Pageof 25

Showing results (211-220 of 245) with videos related to

Sort By:
Pageof 25
AIDS Research and Therapy|October 21, 2022
Correction to: Accuracy of the tuberculosis point-of-care Alere determine lipoarabinomannan antigen diagnostic test using α-mannosidase treated and untreated urine in a cohort of people living with HIV in GuatemalaJuan Ignacio García, Johanna Meléndez, Rosa Álvarez, et al.
Lab Animal|June 4, 2026
The study of immunological markers in tuberculosis across animal models and its translation to human researchSergio Díaz-Fernández, Matilde Aleluia, Margarida Saraiva, et al.
Pathogens (Basel, Switzerland)|December 23, 2022
Differential Role of Type 2 Diabetes as a Risk Factor for Tuberculosis in the Elderly versus Younger AdultsBlanca I Restrepo, Julia M Scordo, Génesis P Aguillón-Durán, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 15, 2021
Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2Kenneth S Plante, Varun Dwivedi, Jessica A Plante, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
Modeling SARS-CoV-2 and Influenza Infections and Antiviral Treatments in Human Lung Epithelial Tissue EquivalentsHoda Zarkoob, Anna Allué-Guardia, Yu-Chi Chen, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
SARS-CoV-2 B.1.1.7 and B.1.351 variants of concern induce lethal disease in K18-hACE2 transgenic mice despite convalescent plasma therapyAlexander M Horspool, Chengjin Ye, Ting Y Wong, et al.
Journal of Virology|September 8, 2021
A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern <i>In Vitro</i> and <i>In Vivo</i>Kevin Chiem, Desarey Morales Vasquez, Jesus A Silvas, et al.
Leukemia Research|October 14, 2023
Venetoclax with hypomethylating agents might lead to eradication of measurable residual disease (MRD) persisting after intensive chemotherapy in acute myeloid leukemia (AML) patients with mutated NPM1 and rearranged CBFCarlos Jiménez-Vicente, Alexandra Martínez-Roca, Helena Pomares, et al.
Research Square|April 1, 2024
Interaction between type 2 diabetes and past COVID-19 on active tuberculosisLiz E Calles-Cabanillas, Genesis P Aguillón-Durán, Doris Ayala, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 22, 2023
Extracellular Delivery of Functional Mitochondria Rescues the Dysfunction of CD4<sup>+</sup> T Cells in AgingColwyn A Headley, Shalini Gautam, Angelica Olmo-Fontanez, et al.
Pageof 25